A low AST means that your aspartate aminotransferase result has landed below the bottom of your laboratory’s reference range, and in the great majority of cases that is not a health problem. AST is measured mainly because doctors want to catch high values, which can point to liver or muscle injury. Low values are usually incidental. There is no recognised “AST deficiency” condition, and a low AST alongside an otherwise normal panel and no symptoms rarely leads to any action at all.
In this article you’ll learn what AST actually is, why the test is designed around high results, how reference ranges create low readings in perfectly healthy people, the one mechanism that genuinely explains a below-range value, the associations researchers have described, and the specific situations where the result is worth raising with your doctor.
What AST is and why it appears on your blood test
AST stands for aspartate aminotransferase, an enzyme that moves a chemical group between two amino acids during protein and energy metabolism. According to MedlinePlus, from the US National Library of Medicine, it is found mainly in the liver but also in the heart, muscles and other tissues. Because it lives inside cells, only a small amount normally leaks into the bloodstream, which is why your baseline blood level is low to begin with.
One detail matters more than it sounds: the enzyme is measured as an activity, not a quantity. The laboratory puts your serum into a controlled reaction and measures how fast it runs, reporting the result in units per liter, written U/L. This comes back in the vitamin B6 section below.
Where the test usually comes from
Most people meet this marker inside a panel rather than as a standalone test. Your doctor typically orders liver function tests or a comprehensive metabolic panel at a routine check-up, and AST arrives as one line among a dozen. For the wider picture, the site has a full guide to liver function tests, and a page explaining the AST (SGOT) blood test.
Why the AST test is really built around high values
Everything about how AST is used clinically points upward. When liver cells are inflamed or damaged they spill their contents into the blood and the measured activity climbs. The same follows significant muscle injury, because skeletal and cardiac muscle also contain the enzyme.
MedlinePlus lists the conditions that raise AST: hepatitis, cirrhosis, mononucleosis, pancreatitis, hemochromatosis, deep burns, seizures, heart problems and procedures, surgery, and substances toxic to the liver, alcohol in particular. Notice what is absent. There is no matching catalogue of conditions that lower AST, because the test was never designed to detect a shortage of the enzyme.
MedlinePlus puts it directly: low levels of AST in the blood are usually considered normal. A number that is meaningful when it rises is not automatically meaningful when it falls.
How reference ranges produce low results in healthy people
This is the explanation most articles skip, and it accounts for the majority of low AST results. A reference range is not a boundary between health and disease; it describes where most people sit. Laboratories build one by measuring a group of apparently healthy volunteers, then drawing lines that exclude the most extreme results at each end. The standard method uses the 2.5th and 97.5th percentiles of that group, an approach published reference-interval studies for AST follow directly.
Do the arithmetic and the consequence is unavoidable. If the range is the middle 95 percent of a healthy population, roughly 5 in every 100 healthy people fall outside it by construction, and about half of those fall below. Being under the line is a designed feature of the method, not a warning signal.
MedlinePlus makes the same point plainly: reference ranges show the average results in a healthy test group, and it is common for healthy people to sometimes have results outside the reference range. It also warns that the word “normal” can be misleading for exactly this reason.
Why two labs can disagree about your result
Reference ranges are lab-specific. Different analysers, reagents and reference populations produce different limits, so you cannot compare a result from one laboratory against the range printed by another. A value flagged low at one lab can sit comfortably inside the range at another, with no change in your health. For more, see the guide to the AST normal range.
The vitamin B6 connection, the one mechanism that genuinely explains a low AST
There is one biological explanation for a low AST that is mechanistically real, and it is the single most valuable fact on this page.
AST cannot work without a helper molecule called pyridoxal 5′-phosphate, abbreviated PLP or P5P, which is the active coenzyme form of vitamin B6. It sits in the enzyme’s active site and makes the reaction possible. Without enough PLP, some of the AST in your sample is present but catalytically idle.
Remember that the laboratory measures activity, not quantity. If part of your AST sits there without its cofactor, the measured activity falls even though the enzyme is there, so a low result can reflect vitamin B6 status rather than anything happening in your liver. This is recognised enough that manufacturers sell AST and ALT reagents both with and without added PLP, and assays that omit it can under-read in people with low vitamin B6. To see how B6 status is measured directly, the site covers the vitamin B6 (PLP) blood test.
Please do not go and buy vitamin B6 because of this
This is where a reader is most likely to do themselves harm, so it needs to be explicit. Reading “low AST can relate to vitamin B6” is not a reason to start a supplement.
Vitamin B6 is not harmless at high doses. The NIH Office of Dietary Supplements reports that chronic intake of 1 to 6 grams of oral pyridoxine per day for 12 to 40 months can cause severe and progressive sensory neuropathy, a nerve condition that includes loss of control of bodily movements. Other reported effects of excess include painful skin lesions, photosensitivity, nausea and heartburn.
For that reason the Food and Nutrition Board set a Tolerable Upper Intake Level, the maximum daily intake unlikely to cause adverse effects, of 100 mg per day for adults aged 19 and over, with lower limits for children. The NIH Office of Dietary Supplements adds that in 2023 a European Food Safety Authority panel reviewing B6 and peripheral neuropathy set a much lower limit of 12 mg per day for adults. The two bodies do not agree, which is itself a reason to leave the decision to a clinician rather than a shelf label.
If vitamin B6 status is genuinely a question in your case, it can be measured. That is a conversation with your doctor, not a purchase.
The other recognised associations, in proportion
Two further associations are real and documented. Both deserve mention, and both deserve to be kept in proportion.
Chronic kidney disease and dialysis
People with reduced kidney function, including those on maintenance dialysis, commonly show lower aminotransferase values, and there is a plausible mechanism. The NIH Office of Dietary Supplements notes that plasma PLP concentrations are low in people receiving maintenance kidney dialysis or intermittent peritoneal dialysis, and in those who have had a kidney transplant, possibly because PLP is cleared faster. End-stage renal disease can itself cause vitamin B6 deficiency.
The practical reading is reassuring. If you already have known kidney disease, a low AST is an expected feature of that situation rather than a new finding, and your kidney team already tracks what matters through a kidney function panel. A low AST does not, by itself, suggest kidney disease in someone with normal kidney results.
Low muscle mass and frailty in older adults
Researchers have studied whether low aminotransferase activity might act as a rough marker of low muscle mass in older people. The logic is simple: muscle contains these enzymes, so less muscle can mean less enzyme in circulation.
Two cautions belong with this immediately. Almost all of this research measured ALT, the sister enzyme, rather than AST. And these are population-level associations from research cohorts, not a diagnostic test: a low AST on your report tells you nothing about your own muscle mass. If muscle is genuinely the question, doctors assess it directly, through grip strength, body composition and markers such as the CPK (creatine phosphokinase) blood test.
What a low AST does not mean
It is worth stating the negatives plainly, because this is where anxiety usually lives.
A low AST is not a sign of a failing liver. Liver injury raises aminotransferases, because a damaged liver leaks more enzyme, not less.
There is no recognised syndrome of AST deficiency, no severity grading for low AST, and no threshold below which a low AST becomes an emergency in an otherwise well person. Any article offering you tiers, stages or a self-monitoring schedule for a low AST is inventing them.
Finally, a low AST is not something you need to “fix”. There is no treatment for it, because in an otherwise normal panel there is nothing being treated.
How doctors actually read a low AST alongside the rest of the panel
A clinician does not read AST in isolation; they read the shape of the whole panel. The first companion is ALT, alanine aminotransferase, the enzyme most specific to the liver. If both are low and everything else is unremarkable, that usually points to the benign explanations already covered: where you sit in the population, the assay your lab uses, or vitamin B6 status. The site has a detailed page on ALT levels.
Doctors also weigh the markers that behave differently from the aminotransferases. Alkaline phosphatase and gamma-glutamyl transferase (GGT) reflect the bile ducts, total bilirubin reflects how the liver clears a waste product, and because it captures synthetic work over weeks they also read the albumin blood test. If those are in range, a lone low AST carries essentially no weight.
A brief word on the AST:ALT ratio
You may have read that the ratio between the two enzymes is diagnostically useful. It can be, but only in one setting: it is interpreted when the enzymes are raised, as a clue to the kind of liver injury present. Dividing one low number by another produces an unstable figure with no established meaning. For context, the site explains the AST/ALT ratio in detail.
| What your result looks like | What it usually means | Usual next step |
|---|---|---|
| Low AST alone, rest of panel in range, no symptoms | Normal variation, or a difference between laboratory assays | Usually nothing; the result is noted and the panel moves on |
| Low AST with a low ALT, no symptoms | One shared explanation for both: population spread, assay, or vitamin B6 status | Your doctor reviews the panel, your medicines and your history |
| Low AST with known kidney disease or on dialysis | An expected pattern in kidney care rather than new information | Already covered by your kidney team’s follow-up |
| Low AST in an older adult losing weight, appetite or strength | Studied as a possible signal of low muscle mass; an association, not a diagnosis | Mention those changes at your next appointment |
| Low AST with symptoms, or other abnormal results on the panel | The symptoms and the other results matter, not the low AST | Discuss with your doctor, who decides on repeating or extending tests |
When it is worth asking your doctor
None of the above means you should ignore your results or diagnose yourself. It means the low AST is rarely the interesting part; what changes the picture is symptoms, or other abnormalities on the same report. Bring the report to your doctor if any of the situations below apply, along with your full medicine list, including over-the-counter products and supplements.
| When it is worth talking to your doctor |
|---|
| You have symptoms alongside the result: persistent fatigue, unintended weight loss, muscle weakness, yellowing of the skin or eyes, abdominal pain or swelling, or dark urine |
| Other markers on the same panel are outside their ranges, especially bilirubin, albumin, alkaline phosphatase or the blood count |
| You have kidney disease, are on dialysis, or have a condition affecting nutrient absorption such as coeliac disease or inflammatory bowel disease |
| You take a medicine known to affect vitamin B6, such as certain antiepileptic drugs, and have not reviewed this with your prescriber |
| You are an older adult who has noticed a real change in strength, appetite or weight in recent months |
| You are simply worried and would like the result explained in the context of your own history |
If you would like help reading the rest of the report before that conversation, the site has a general guide on how to read blood test results.
Latest scientific advances in understanding low AST
The research below comes from studies indexed in PubMed, with two honest caveats. The literature on low AST specifically is thin: most of this work studied ALT, the sister enzyme. And all of it is observational, meaning researchers watched what happened rather than testing an intervention. Association is not causation, and none of these findings is a diagnosis.
Laboratory reagents differ in whether they add the vitamin B6 cofactor
A 2025 survey by the College of American Pathologists Clinical Chemistry Committee, from Chambliss and colleagues, asked American laboratories whether their AST and ALT reagents contain added pyridoxal 5′-phosphate. What was found: only a minority used reagents with the cofactor, and the authors called for manufacturers to standardise them, noting that assays without it may under-read in people with vitamin B6 deficiency. What this means for you: part of why your AST reads low may come down to which reagent your laboratory buys, a property of the test rather than of your body. See DOI 10.5858/arpa.2024-0097-CP.
Reading both aminotransferases together carries more information than either alone
Gallo and colleagues analysed InCHIANTI, a long-running population study of older Italians, publishing in 2021. What was found: for AST the relationship with later outcomes formed a U-shape, so the lowest and highest groups both fared less well than the middle, and low values travelled with frailty, sarcopenia (age-related loss of muscle mass and strength) and difficulty with daily activities. What this means for you: in older adults a very low value tends to accompany reduced physical reserve rather than acting as a stand-alone signal. It identifies no disease, and says nothing about a younger person with a normal panel. See DOI 10.1007/s40520-021-01979-9.
The foundational study that linked low ALT to frailty, and to vitamin B6
Vespasiani-Gentilucci and colleagues followed a cohort (a group tracked over time) of adults over 65 without liver disease, cancer or alcohol misuse, publishing in 2018. What was found: lower ALT activity went together with frailty, disability, sarcopenia and pyridoxine (vitamin B6) deficiency, and the authors concluded it is better read as a marker of frailty than as a liver finding. What this means for you: this is the origin of the frailty association you may read elsewhere, and evidence that vitamin B6 status is entangled with these readings. Every participant was over 65. See DOI 10.1093/gerona/glx126.
The pattern also appears in people with chronic kidney disease
Agidew and colleagues published a 2025 cross-sectional study, measuring everything at one point in time, in adults with chronic kidney disease in Ethiopia. What was found: ALT was lower in older patients than younger ones, and lower values tracked with frailty. What this means for you: it supports the observation that kidney disease and older age both pull these enzymes downward, which is why a low result in someone under kidney care is unsurprising. It is a single-centre study, so read it as one piece of evidence. See DOI 10.3389/fmed.2025.1524459.
Reference intervals really are built from percentiles of healthy volunteers
Bakrim and colleagues established reference intervals for routine biochemistry, AST included, in apparently healthy Moroccan adults, publishing in 2023. What was found: the limits were set at the 2.5th and 97.5th percentiles of the healthy group, and the authors stressed that intervals borrowed from other populations can mislead. What this means for you: your report’s lower limit reflects where a group of healthy volunteers happened to sit, which is precisely why healthy people land below it. See DOI 10.7754/Clin.Lab.2022.220814.
Glossary of key terms
| Term | Definition |
|---|---|
| AST (aspartate aminotransferase) | An enzyme found mainly in the liver but also in the heart, muscles and other tissues; also called SGOT |
| ALT (alanine aminotransferase) | The sister enzyme to AST, more specific to the liver; also called SGPT |
| Enzyme activity | How fast an enzyme makes its reaction run, which is what the laboratory measures rather than the amount of enzyme present |
| U/L | Units per liter, the measurement used to report enzyme activity in blood |
| Reference interval | The range of results seen in most of a healthy reference group, usually defined by the 2.5th and 97.5th percentiles |
| Pyridoxal 5′-phosphate (PLP or P5P) | The active coenzyme form of vitamin B6, required by AST and ALT to work |
| Cofactor | A helper molecule an enzyme needs before it can carry out its reaction |
| Tolerable Upper Intake Level (UL) | The maximum daily intake of a nutrient that is unlikely to cause adverse health effects |
| Sarcopenia | The age-related loss of muscle mass and strength |
| Cohort study | A study that follows a defined group of people over time to see what happens to them |
Frequently asked questions
Should I worry about a low AST?
Usually, no. If the rest of your panel is in range and you feel well, a low AST on its own is not considered a health problem, and MedlinePlus states that low AST levels in the blood are usually considered normal. A reference range is built so that a small percentage of perfectly healthy people fall below it, so somebody has to be that person and it may simply be you. What would change the picture is symptoms, or other results on the same report that are outside their ranges. In that case the low AST is still not the issue; the symptoms and the other results are, and they belong with your doctor.
Should I take vitamin B6 because my AST is low?
Not on your own initiative. It is true that AST needs vitamin B6, in its active form pyridoxal 5′-phosphate, to work, and that low B6 status can lower the measured activity. That is a reason to ask a question, not to buy a supplement. High-dose vitamin B6 can cause real harm: the NIH Office of Dietary Supplements reports that sustained high intakes of oral pyridoxine can cause severe and progressive sensory neuropathy, and the Food and Nutrition Board set a Tolerable Upper Intake Level of 100 mg per day for adults, while a European Food Safety Authority panel proposed a much lower limit of 12 mg per day in 2023. If B6 is a genuine question in your case, it can be measured, and any decision about supplementing belongs to your doctor.
What does it mean if my AST and ALT are both low?
Most often it means one explanation covers both, since the two enzymes share the same vitamin B6 cofactor and the same reference-range logic. Common benign reasons include simply sitting at the lower end of the population distribution, the particular reagent your laboratory uses, or lower vitamin B6 status. In older adults, research has described low values travelling together with reduced physical reserve, but that is an observation across populations, not a test result you can apply to yourself. Your doctor will look at the rest of the panel, your medicines and your history before drawing any conclusion, and in a well person with an otherwise normal panel, the usual conclusion is that no action is needed.
Can a low AST mean my liver is failing?
No. This gets the biology backwards. AST sits inside liver cells, and a damaged or inflamed liver releases more of it into the blood, which is why liver injury raises the value rather than lowering it. Liver failure is identified through other findings entirely, including bilirubin, albumin, clotting tests, imaging and symptoms such as jaundice or fluid retention. A low AST is not part of that picture. If you do have symptoms that worry you, they deserve attention on their own merits, and you should see your doctor about the symptoms rather than about the AST number.
Should a low AST be retested?
Often it is not retested at all, because there is nothing to follow. Doctors repeat a test when the result would change what they do, and an isolated low AST in a well person with a normal panel usually would not. Your doctor may repeat it if the wider panel was abnormal, if your symptoms suggest something worth tracking, or if they want to compare against a different laboratory method. It is reasonable to ask whether a repeat is planned and why. If you do have it rechecked, using the same laboratory makes the comparison more meaningful, since reference ranges and methods differ between labs.
Can medicines, pregnancy or diet lower my AST?
Some medicines are known to affect vitamin B6 status, including certain antiepileptic drugs, which the NIH Office of Dietary Supplements lists as increasing the breakdown of vitamin B6. Since AST depends on that vitamin, an effect on the measured activity is plausible. Reduced vitamin B6 status is also described in people with alcohol dependence, in some malabsorption conditions such as coeliac disease and inflammatory bowel disease, and in kidney disease. Rather than trying to work out which factor applies to you, bring your complete medicine and supplement list to your appointment and mention any relevant condition or pregnancy. That context is what allows your doctor to interpret the result properly.
Sources
- MedlinePlus, US National Library of Medicine — AST Test
- MedlinePlus, US National Library of Medicine — How to Understand Your Lab Results
- MedlinePlus, US National Library of Medicine — Liver Function Tests
- NIH Office of Dietary Supplements — Vitamin B6, Fact Sheet for Health Professionals
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Liver Disease
- Chambliss AB, Souers RJ, Genzen JR, Manthei DM. Reported Awareness and Use of Pyridoxal-5′-Phosphate Supplementation in Alanine Aminotransferase and Aspartate Aminotransferase Assay Reagents: A Survey by the College of American Pathologists Clinical Chemistry Committee. Arch Pathol Lab Med. 2025;149(5):400-404
- Gallo P, De Vincentis A, Bandinelli S, Ferrucci L, Picardi A, Antonelli Incalzi R, Vespasiani-Gentilucci U. Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients. Aging Clin Exp Res. 2021;33(12):3321-3331
- Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, Bandinelli S, Antonelli Incalzi R, Picardi A. Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival. J Gerontol A Biol Sci Med Sci. 2018;73(7):925-930
- Agidew MM, Mulu AT, Teklemariam AB, Mengstie MA, Melake A, Zewde EA, Muche ZT, Dagnew SB, Baye ND, Adane B, Walle M, Derso G. Impact of aging on alanine aminotransferase levels and frailty in chronic kidney disease patients: laboratory-based cross-sectional study in Northwest Ethiopia. Front Med (Lausanne). 2025;12:1524459
- Bakrim S, Ouarour A, Buya AB, Aboulaghras S, Bouyahya A, Masrar A. Reference Intervals for Routine Biochemical Markers and Hematological Indices Derived from Healthy Adults in the Mediterranean Region of Morocco. Clin Lab. 2023;69(2)
Further reading
- AST (SGOT) test: demystifying liver enzyme results
- ALT (SGPT) blood test and the liver
- Alkaline phosphatase (ALP) test results
- LDH (lactate dehydrogenase) blood test interpretation
- Creatinine, the blood marker of kidney function
A single line on a lab report is hard to place without the rest of the picture. AI DiagMe reads your report as a whole, so markers such as AST, ALT, albumin and the wider liver function tests are explained in relation to one another rather than one at a time. It helps you understand what you are looking at and prepare better questions. It does not diagnose anything and it does not replace your doctor.
Understand your lab results with AI DiagMe
Get your results interpreted in minutes
